Published on 7/31/2007 in the Prospect News PIPE Daily.
New Issue: Orthovita settles $32.5 million stock offering
By Sheri Kasprzak
New York, July 31 - Orthovita, Inc. concluded a private placement of stock for $32,517,054.
The company sold 12,317,066 shares at $2.64 each to Essex Woodland Health Ventures Fund VII, LP; Lehman Brothers Inc.; Magnetar Capital Master Fund, Ltd.; W.H.I. Growth Fund Q.P., LP; WHI Select Fund, LP; Panacea Fund, LLC; and Stephen F. Wiggins.
Also, the company entered into a note and warrant agreement with those investors for up to $45 million.
The 10% notes are due July 30, 2012 and include warrants for 1,466,276 shares, exercisable at $3.41 each through July 30, 2012.
So far, the company has sold $25 million in principal of the notes.
Orthovita, based in Malvern, Pa., develops synthetic biomaterials used in spinal surgery.
Stock offering
Issuer: | Orthovita, Inc.
|
Issue: | Stock
|
Amount: | $32,517,054
|
Shares: | 12,317,066
|
Price: | $2.64
|
Warrants: | No
|
Investors: | Essex Woodland Health Ventures Fund VII, LP; Lehman Brothers Inc.; Magnetar Capital Master Fund, Ltd.; W.H.I. Growth Fund Q.P., LP; WHI Select Fund, LP; Panacea Fund, LLC; and Stephen F. Wiggins
|
Settlement date: | July 30
|
Stock symbol: | Nasdaq: VITA
|
Stock price: | $3.17 at close July 30
|
|
Note offering
|
Issuer: | Orthovita, Inc.
|
Issue: | Notes
|
Amount: | $45 million (maximum)
|
Maturity: | July 30, 2012
|
Coupon: | 10%
|
Price: | Par
|
Yield: | 10%
|
Warrants: | For 1,466,276 shares
|
Warrant expiration: | July 30, 2012
|
Warrant strike price: | $3.41
|
Investors: | Essex Woodland Health Ventures Fund VII, LP; Lehman Brothers Inc.; Magnetar Capital Master Fund, Ltd.; W.H.I. Growth Fund Q.P., LP; WHI Select Fund, LP; Panacea Fund, LLC; and Stephen F. Wiggins
|
Settlement date: | July 30
|
Stock symbol: | Nasdaq: VITA
|
Stock price: | $3.17 at close July 30
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.